Wells Fargo’s Eloxx Pharmaceuticals ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.93K Hold
126
– – ﹤0.01% 6409
2026
Q2
$1.75K Buy
+126
New +$1.61K ﹤0.01% 6381

Other funds holding ELOX

Wells Fargo's ELOX Position: Q3 2026 in Review

Wells Fargo held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 126 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #6409.

Wells Fargo first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.

  • Wells Fargo held 126 shares of Eloxx Pharmaceuticals worth $1.93K as of Q3 2026.
  • Wells Fargo left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
  • Eloxx Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6409 holding.
  • Wells Fargo first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.